Strengthening accrual to cancer clinical trials

Edward L. Trimble; Andrea M. Denicoff; Jeffrey S. Abrams

doi:10.1016/j.ygyno.2010.01.015

Strengthening accrual to cancer clinical trials

Edward L. Trimble, Andrea M. Denicoff, Jeffrey S. Abrams

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	291-292
Number of pages	2
Journal	Gynecologic oncology
Volume	116
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2010.01.015
State	Published - Mar 2010
Externally published	Yes

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2010.01.015

Cite this

@article{6ba59db7efcf4ced8fe8b24fa1e17a62,

title = "Strengthening accrual to cancer clinical trials",

author = "Trimble, {Edward L.} and Denicoff, {Andrea M.} and Abrams, {Jeffrey S.}",

note = "Funding Information: The National Cancer Institute (NCI)'s strong commitment to prospective clinical trials dates to 1955, when the US Congress established the National Cancer Chemotherapy Service Center, prompted by oncologists and patient advocates, led by Dr. Sidney Farber and Mrs. Mary Lasker. The NCI now supports clinical trials through 12 multi-institutional cooperative groups, 58 clinical and comprehensive cancer centers, 67 Specialized Programs of Research Excellence, and a variety of consortia, grants, and contracts. Recent initiatives by the NCI, working with partners in academia, industry, and the advocacy community, to strengthen the NCI's clinical trials system have included efforts to shorten the times for protocol development and speed trial accrual, with the ultimate goal to get improved cancer treatments to patients sooner [1] . ",

year = "2010",

month = mar,

doi = "10.1016/j.ygyno.2010.01.015",

language = "English (US)",

volume = "116",

pages = "291--292",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Strengthening accrual to cancer clinical trials

AU - Trimble, Edward L.

AU - Denicoff, Andrea M.

AU - Abrams, Jeffrey S.

N1 - Funding Information: The National Cancer Institute (NCI)'s strong commitment to prospective clinical trials dates to 1955, when the US Congress established the National Cancer Chemotherapy Service Center, prompted by oncologists and patient advocates, led by Dr. Sidney Farber and Mrs. Mary Lasker. The NCI now supports clinical trials through 12 multi-institutional cooperative groups, 58 clinical and comprehensive cancer centers, 67 Specialized Programs of Research Excellence, and a variety of consortia, grants, and contracts. Recent initiatives by the NCI, working with partners in academia, industry, and the advocacy community, to strengthen the NCI's clinical trials system have included efforts to shorten the times for protocol development and speed trial accrual, with the ultimate goal to get improved cancer treatments to patients sooner [1] .

PY - 2010/3

Y1 - 2010/3

UR - http://www.scopus.com/inward/record.url?scp=75749109798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749109798&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2010.01.015

DO - 10.1016/j.ygyno.2010.01.015

M3 - Editorial

C2 - 20152512

AN - SCOPUS:75749109798

VL - 116

SP - 291

EP - 292

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -

Strengthening accrual to cancer clinical trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this